GeneDx Holdings Corp
WGS134.320USD
-1.770-1.30%
交易中 （美东）报价延迟15分钟
3.88B总市值
1237.74市盈率 TTM
关于 GeneDx Holdings Corp 公司
GeneDx Holdings Corp. is a genomics company. The Company operates, through its subsidiary, GeneDx, LLC, which is focused on exome and genome tests that translate complex genomic data into clinical answers that unlock personalized health plans, accelerate drug discovery, and improve health system efficiencies. It operates through GeneDx segment, which primarily provides pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing and, to a lesser extent, data and information services. Exome sequencing test options include XomeDx, XomeDx Plus, and XomeDxXpress. GeneDx genome sequencing evaluates the protein-coding and non-coding regions of an individual’s nuclear genome. GeneDx genome sequencing test options include GenomeSeqDx and GenomeXpress. It offers a menu of targeted variant testing options to meet the needs of families and healthcare providers. Its subsidiary, Fabric Genomics, Inc., specializes in artificial intelligence-powered genomic interpretation.
GeneDx Holdings Corp简介
公司代码WGS
公司名称GeneDx Holdings Corp
上市日期Sep 04, 2020
CEOStueland (Katherine A)
员工数量1000
证券类型Ordinary Share
年结日Sep 04
公司地址333 Ludlow Street
城市STAMFORD
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编06902
电话18887291206
网址https://sema4.com/
公司代码WGS
上市日期Sep 04, 2020
CEOStueland (Katherine A)
GeneDx Holdings Corp公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Joshua Ruch
Mr. Joshua Ruch
Independent Director
Independent Director
223.99K
+6.12%
Dr. Emily M. Leproust, Ph.D.
Dr. Emily M. Leproust, Ph.D.
Independent Director
Independent Director
33.16K
+63.87%
Mr. Kevin Feeley
Mr. Kevin Feeley
Chief Financial Officer
Chief Financial Officer
4.46K
+8.26%
Mr. Keith A. Meister
Mr. Keith A. Meister
Independent Director
Independent Director
3.58K
-82.23%
Dr. Thomas Fuchs
Dr. Thomas Fuchs
Director
Director
--
--
Dr. Bryan Dechairo
Dr. Bryan Dechairo
Chief Operating Officer
Chief Operating Officer
--
--
Ms. Katherine A. Stueland
Ms. Katherine A. Stueland
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Jason Michael Ryan, CPA
Mr. Jason Michael Ryan, CPA
Chairman of the Board
Chairman of the Board
--
--
Mr. Eli D. Casdin
Mr. Eli D. Casdin
Independent Director
Independent Director
--
--
Mr. Richard C. (Rick) Pfenniger, Jr.
Mr. Richard C. (Rick) Pfenniger, Jr.
Independent Director
Independent Director
--
--
名称
名称/职务
职务
持股
持股变动
Mr. Joshua Ruch
Mr. Joshua Ruch
Independent Director
Independent Director
223.99K
+6.12%
Dr. Emily M. Leproust, Ph.D.
Dr. Emily M. Leproust, Ph.D.
Independent Director
Independent Director
33.16K
+63.87%
Mr. Kevin Feeley
Mr. Kevin Feeley
Chief Financial Officer
Chief Financial Officer
4.46K
+8.26%
Mr. Keith A. Meister
Mr. Keith A. Meister
Independent Director
Independent Director
3.58K
-82.23%
Dr. Thomas Fuchs
Dr. Thomas Fuchs
Director
Director
--
--
Dr. Bryan Dechairo
Dr. Bryan Dechairo
Chief Operating Officer
Chief Operating Officer
--
--
收入明细
单位: USD更新时间: 10月6日 周一
单位: USD更新时间: 10月6日 周一
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
业务USD
名称
营收
占比
Patients with third party insurance
81.10M
78.98%
Institutional customers
18.38M
17.90%
Other
2.87M
2.79%
Self pay patients
339.00K
0.33%
由于公司未披露，未能获取相关数据
业务
地区
业务USD
名称
营收
占比
Patients with third party insurance
81.10M
78.98%
Institutional customers
18.38M
17.90%
Other
2.87M
2.79%
Self pay patients
339.00K
0.33%
股东统计
更新时间: 12月3日 周三
更新时间: 12月3日 周三
持股股东
股东类型
持股股东
持股股东
占比
Corvex Management LP
10.58%
Casdin Capital, LLC
10.40%
Icahn School of Medicine at Mount Sinai
4.75%
OPKO Health Inc
4.74%
BlackRock Institutional Trust Company, N.A.
4.56%
其他
64.96%
持股股东
持股股东
占比
Corvex Management LP
10.58%
Casdin Capital, LLC
10.40%
Icahn School of Medicine at Mount Sinai
4.75%
OPKO Health Inc
4.74%
BlackRock Institutional Trust Company, N.A.
4.56%
其他
64.96%
股东类型
持股股东
占比
Investment Advisor/Hedge Fund
34.29%
Investment Advisor
31.31%
Hedge Fund
30.92%
Corporation
10.65%
Research Firm
6.78%
Individual Investor
1.68%
Pension Fund
0.76%
Bank and Trust
0.40%
Venture Capital
0.31%
机构持股
更新时间: 10月1日 周三
更新时间: 10月1日 周三
报告期
机构数
持股数
持股占比
持股变动
2025Q3
446
32.52M
112.51%
-918.42K
2025Q2
397
34.23M
119.24%
+1.02M
2025Q1
398
32.79M
115.46%
-47.86K
2024Q4
341
29.17M
104.22%
+1.72M
2024Q3
289
26.18M
97.50%
+377.48K
2024Q2
262
24.98M
95.33%
+588.25K
2024Q1
260
22.13M
86.19%
+1.41M
2023Q4
271
20.57M
80.67%
-567.28K
2023Q3
283
21.68M
85.29%
-751.02K
2023Q2
291
21.85M
86.03%
-864.88K
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Corvex Management LP
3.06M
10.65%
--
--
Aug 22, 2025
Casdin Capital, LLC
3.05M
10.6%
-461.51K
-13.16%
Aug 22, 2025
Icahn School of Medicine at Mount Sinai
1.37M
4.78%
-1.35M
-49.50%
Feb 21, 2025
OPKO Health Inc
1.37M
4.77%
-800.83K
-36.88%
Nov 20, 2024
BlackRock Institutional Trust Company, N.A.
1.28M
4.45%
+241.28K
+23.25%
Jun 30, 2025
William Blair Investment Management, LLC
1.63M
5.68%
+442.41K
+37.21%
Jun 30, 2025
The Vanguard Group, Inc.
1.18M
4.09%
+148.96K
+14.50%
Jun 30, 2025
Goldman Sachs & Company, Inc.
973.26K
3.39%
-59.05K
-5.72%
Jun 30, 2025
Oracle Investment Management, Inc.
922.45K
3.21%
-47.50K
-4.90%
Jun 30, 2025
Summit Partners Public Asset Management, LLC
767.26K
2.67%
-435.26K
-36.20%
Jun 30, 2025
查看更多
持股ETF
更新时间: 12月6日 周六
更新时间: 12月6日 周六
机构名称
占比
Global X Genomics & Biotechnology ETF
3.84%
Franklin Genomic Advancements ETF
3.47%
Clough Hedged Equity ETF
2.89%
Clough Select Equity ETF
2.65%
State Street SPDR S&P Health Care Services ETF
2.27%
Harbor Health Care ETF
1.85%
Innovator IBD Breakout Opportunities ETF
1.52%
ARK Genomic Revolution ETF
1.29%
Main Thematic Innovation ETF
1.29%
Invesco Dorsey Wright Healthcare Momentum ETF
1.18%
查看更多
Global X Genomics & Biotechnology ETF
占比3.84%
Franklin Genomic Advancements ETF
占比3.47%
Clough Hedged Equity ETF
占比2.89%
Clough Select Equity ETF
占比2.65%
State Street SPDR S&P Health Care Services ETF
占比2.27%
Harbor Health Care ETF
占比1.85%
Innovator IBD Breakout Opportunities ETF
占比1.52%
ARK Genomic Revolution ETF
占比1.29%
Main Thematic Innovation ETF
占比1.29%
Invesco Dorsey Wright Healthcare Momentum ETF
占比1.18%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
Apr 28, 2023
Merger
33→1
Apr 28, 2023
Merger
33→1
Apr 28, 2023
Merger
33→1
Apr 28, 2023
Merger
33→1
公告日期
类型
比率
Apr 28, 2023
Merger
33→1
Apr 28, 2023
Merger
33→1
Apr 28, 2023
Merger
33→1
Apr 28, 2023
Merger
33→1
常见问题
GeneDx Holdings Corp的前五大股东是谁？
GeneDx Holdings Corp 的前五大股东如下：
Corvex Management LP持有股份：3.06M，占总股份比例：10.65%。
Casdin Capital, LLC持有股份：3.05M，占总股份比例：10.60%。
Icahn School of Medicine at Mount Sinai持有股份：1.37M，占总股份比例：4.78%。
OPKO Health Inc持有股份：1.37M，占总股份比例：4.77%。
BlackRock Institutional Trust Company, N.A.持有股份：1.28M，占总股份比例：4.45%。
Corvex Management LP持有股份：3.06M，占总股份比例：10.65%。
Casdin Capital, LLC持有股份：3.05M，占总股份比例：10.60%。
Icahn School of Medicine at Mount Sinai持有股份：1.37M，占总股份比例：4.78%。
OPKO Health Inc持有股份：1.37M，占总股份比例：4.77%。
BlackRock Institutional Trust Company, N.A.持有股份：1.28M，占总股份比例：4.45%。
GeneDx Holdings Corp的前三大股东类型是什么？
GeneDx Holdings Corp 的前三大股东类型分别是：
Corvex Management LP
Casdin Capital, LLC
Icahn School of Medicine at Mount Sinai
Corvex Management LP
Casdin Capital, LLC
Icahn School of Medicine at Mount Sinai
有多少机构持有GeneDx Holdings Corp(WGS)的股份？
截至2025Q3，共有446家机构持有GeneDx Holdings Corp的股份，合计持有的股份价值约为32.52M，占公司总股份的112.51%。与2025Q2相比，机构持股有所增加，增幅为-6.72%。
哪个业务部门对GeneDx Holdings Corp的收入贡献最大？
在FY2025Q2，Patients with third party insurance业务部门对GeneDx Holdings Corp的收入贡献最大，创收81.10M，占总收入的78.98%。
